Jun 9, 2026 12:51PM
Jun 9, 2026 06:51AM
Mar 10, 2026 08:30AM
Oct 17, 2025 07:21AM
Aug 12, 2025 04:05PM
Apr 21, 2025 07:22AM
Apr 21, 2025 07:22AM Zevra Files Definitive Proxy Statement and Mails Letter to Stockholders
Mar 31, 2025 04:12PM
Mar 31, 2025 04:12PM
Mar 11, 2025 04:05PM
Nov 21, 2024 04:53PM
Nov 21, 2024 04:51PM
Nov 11, 2024 04:40PM
Nov 11, 2024 04:36PM Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
Sep 30, 2024 07:26AM
Sep 24, 2024 07:56AM
Sep 24, 2024 05:40AM
Sep 23, 2024 06:35AM
Sep 20, 2024 12:08PM
Sep 20, 2024 12:08PM
Sep 20, 2024 10:14AM US FDA approves Zevra's treatment for rare genetic disease
Sep 20, 2024 09:49AM
Sep 6, 2024 10:14AM
Aug 2, 2024 05:50PM
Jul 10, 2024 08:29AM
Jul 9, 2024 02:17PM
Jul 9, 2024 09:06AM
Apr 15, 2024 05:02PM Zevra Therapeutics (ZVRA) Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C
Apr 15, 2024 05:01PM
Mar 28, 2024 04:32PM
Mar 12, 2024 06:01AM
Mar 4, 2024 07:50AM
Dec 27, 2023 07:33AM
Aug 31, 2023 07:30AM
Jul 19, 2023 07:30AM Zevra Therapeutics to Participate in the 2023 NNPDF Family Support and Medical Conference
Jun 20, 2023 07:31AM
Jun 20, 2023 07:30AM
Jun 13, 2023 07:30AM
Jun 5, 2023 05:54AM
Jun 3, 2023 07:30AM
May 15, 2023 04:05PM
May 10, 2023 07:30AM Zevra Therapeutics will Participate in RBC Capital Markets Global Healthcare Conference on May 16, 2023
May 9, 2023 07:30AM
May 8, 2023 07:31AM
May 8, 2023 07:30AM
May 3, 2023 07:32AM
May 3, 2023 07:30AM
Apr 17, 2023 04:05PM
Apr 4, 2023 07:31AM Zevra Therapeutics (ZVRA) Announces Submission of IND for KP1077 in Narcolepsy
Apr 4, 2023 07:30AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All